drugset / Trial / NCT00846014

Asthma Exacerbation and Helium-3 MRI

NCT00846014

NaSingle-groupOpen-labelDiagnostic

Summary

The goal of this research is to use Helium-3 MRI to see the changes in airflow of the lungs at different times of an attack. These three stages are immediately after the attack, 1 month later and 4-6 months later.

Timeline

Start
2009-01
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Helium-3 Diagnostic / imaging agent 333 ml Inhaled

Indications